Neurotech Appoints Beth Marsh as Chief Commercial Officer
21 Apr 2025 //
BUSINESSWIRE
Orsini Exclusive Specialty Pharmacy for Cell Therapy Encelto
01 Apr 2025 //
PR NEWSWIRE
Neurotech’s Encelto Approved by the FDA for Macular Telangiectasia
06 Mar 2025 //
BUSINESSWIRE
UNEEG Medical Gets FDA Breakthrough Device Designation
25 Nov 2024 //
ACCESSWIRE
Neurotech Updates BLA for NT-501 in MacTel Treatment
08 Nov 2024 //
BUSINESSWIRE
Neurotech Innovation Achieves Patent And Journal Cover Feature
09 Aug 2024 //
GLOBENEWSWIRE
Neurotech`s NT-501 For MacTel Treatment Receives Priority BLA Review
20 Jun 2024 //
BUSINESSWIRE
Alex Gorsky Joins Neurotech’s Board as Lead Director
13 Sep 2023 //
BUSINESSWIRE
Neurotech Appoints Scott Hunter as Chief Commercial Officer
10 Jan 2023 //
BUSINESSWIRE